Sapio Sciences and Ultima Genomics partner to advance multi-omics research

Sapio Sciences, the science-aware lab informatics platform, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio’s AI-powered lab informatics solutions with Ultima’s high-throughput, low-cost sequencing platform. Together, the companies will deliver efficient, traceable, and unified workflows for multi-omics research and clinical genomics.

Ultima Genomics is known for its innovative ultra-high throughput sequencing architecture, designed to drive down sequencing costs and scale beyond conventional technologies. Its multiomics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone. Many changes linked to disease occur first in other omic layers, such as in the epigenome with cancer.

Deeper levels of analysis are increasingly important for understanding complex biology, but until now have often required multiple costly assays and fragmented workflows. This integration allows researchers and clinicians to combine Ultima’s data generation capabilities with Sapio’s analytics, automation, and data management tools for a seamless, end-to-end solution.

Gilad Almogy, CEO and founder of Ultima Genomics, commented, “Partnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable. By integrating our high-throughput, low-cost sequencing platform with Sapio’s AI-powered lab informatics platform, we’re enabling a seamless, scalable solution for multi-omics research and clinical genomics.

Almogy continued, “We’re excited to empower organizations to accelerate discovery, drive AI-powered insights, and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.”

Key benefits for customers

  • Integrated workflows: Unify sequencing and informatics into a single environment, so researchers avoid fragmented assays.
  • Lower cost per sample: Reduce per-sample costs with ultra-high throughput sequencing.
  • Faster discovery cycles: Accelerate discovery cycles with AI-driven analytics and automation.
  • Improved traceability: Ensure compliance through end-to-end data provenance tracking.
  • Future-ready architecture: Support genomics, transcriptomics, proteomics, and other omics fields with a future-ready architecture.

This partnership gives Ultima’s customers a direct path to combining world-class sequencing with equally powerful informatics.

By removing workflow complexity, we’re making it easier for labs to manage multi-omics data, gain insights faster, and scale without compromising quality or compliance.”

Andrew Wyatt, Chief Growth Officer, Sapio Sciences

Sapio Sciences partner program

The Sapio Sciences Partner Program connects innovators with Sapio’s industry-leading lab informatics platform, fostering integrations that deliver measurable benefits to customers. It includes three partner ecosystems:

  • Technology partners: Hardware, cloud, and software vendors that extend the platform through integration, hosting, and solution development.
  • Services partners: Advisory and implementation experts who guide customers through lab automation and deployment.
  • Reseller partners: Value-Added Resellers (VARs) and consultants who resell Sapio solutions and add value through customization, integration, training, and support.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sapio Sciences. (2025, September 10). Sapio Sciences and Ultima Genomics partner to advance multi-omics research. News-Medical. Retrieved on September 10, 2025 from https://www.news-medical.net/news/20250910/Sapio-Sciences-and-Ultima-Genomics-partner-to-advance-multi-omics-research.aspx.

  • MLA

    Sapio Sciences. "Sapio Sciences and Ultima Genomics partner to advance multi-omics research". News-Medical. 10 September 2025. <https://www.news-medical.net/news/20250910/Sapio-Sciences-and-Ultima-Genomics-partner-to-advance-multi-omics-research.aspx>.

  • Chicago

    Sapio Sciences. "Sapio Sciences and Ultima Genomics partner to advance multi-omics research". News-Medical. https://www.news-medical.net/news/20250910/Sapio-Sciences-and-Ultima-Genomics-partner-to-advance-multi-omics-research.aspx. (accessed September 10, 2025).

  • Harvard

    Sapio Sciences. 2025. Sapio Sciences and Ultima Genomics partner to advance multi-omics research. News-Medical, viewed 10 September 2025, https://www.news-medical.net/news/20250910/Sapio-Sciences-and-Ultima-Genomics-partner-to-advance-multi-omics-research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations